5-(8-chloroquinolin-6-yl)-3-[(1-methylpiperidin-4-yl)methylsulfanyl]-6-(1-methylpyrazol-3-yl)pyrazin-2-amine
C24H26ClN7S — CID 137431274
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(8-chloroquinolin-6-yl)-3-[(1-methylpiperidin-4-yl)methylsulfanyl]-6-(1-methylpyrazol-3-yl)pyrazin-2-amine
5-(8-chloroquinolin-6-yl)-3-[(1-methylpiperidin-4-yl)methylsulfanyl]-6-(1-methylpyrazol-3-yl)pyrazin-2-amine (PubChem CID 137431274) has the molecular formula C24H26ClN7S and a molecular weight of 480.04 g/mol. Its IUPAC name is 5-(8-chloroquinolin-6-yl)-3-[(1-methylpiperidin-4-yl)methylsulfanyl]-6-(1-methylpyrazol-3-yl)pyrazin-2-amine.
Molecular Properties
| Compound Name | 5-(8-chloroquinolin-6-yl)-3-[(1-methylpiperidin-4-yl)methylsulfanyl]-6-(1-methylpyrazol-3-yl)pyrazin-2-amine |
|---|---|
| PubChem CID | 137431274 |
| Molecular Formula | C24H26ClN7S |
| Molecular Weight | 480.04 g/mol |
| Exact Mass | 479.17 |
| IUPAC Name | 5-(8-chloroquinolin-6-yl)-3-[(1-methylpiperidin-4-yl)methylsulfanyl]-6-(1-methylpyrazol-3-yl)pyrazin-2-amine |
| SMILES | CN1CCC(CSc2nc(-c3cc(Cl)c4ncccc4c3)c(-c3ccn(C)n3)nc2N)CC1 |
| InChI | InChI=1S/C24H26ClN7S/c1-31-9-5-15(6-10-31)14-33-24-23(26)28-22(19-7-11-32(2)30-19)21(29-24)17-12-16-4-3-8-27-20(16)18(25)13-17/h3-4,7-8,11-13,15H,5-6,9-10,14H2,1-2H3,(H2,26,28) |
| InChIKey | LERIBTJWMWDPBI-UHFFFAOYSA-N |
| XLogP | 4.76 |
| TPSA | 85.75 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.04 |
| LogP ≤ 5 | 4.76 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137431274 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.